Douglas Lane & Associates LLC decreased its holdings in Oracle Co. (NYSE:ORCL - Free Report) by 2.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 553,279 shares of the enterprise software provider's stock after selling 13,109 shares during the quarter. Oracle accounts for about 1.1% of Douglas Lane & Associates LLC's holdings, making the stock its 26th biggest holding. Douglas Lane & Associates LLC's holdings in Oracle were worth $77,354,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also made changes to their positions in ORCL. Capital & Planning LLC boosted its stake in shares of Oracle by 0.5% in the fourth quarter. Capital & Planning LLC now owns 15,727 shares of the enterprise software provider's stock valued at $2,621,000 after purchasing an additional 81 shares during the period. Brighton Jones LLC lifted its stake in Oracle by 189.3% in the fourth quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider's stock worth $25,593,000 after acquiring an additional 100,494 shares during the last quarter. Union Bancaire Privee UBP SA purchased a new position in Oracle in the fourth quarter worth approximately $51,084,000. Revolve Wealth Partners LLC lifted its stake in Oracle by 8.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider's stock worth $903,000 after acquiring an additional 404 shares during the last quarter. Finally, R Squared Ltd purchased a new position in Oracle in the fourth quarter worth approximately $25,000. Hedge funds and other institutional investors own 42.44% of the company's stock.
Insider Buying and Selling
In related news, Director Naomi O. Seligman sold 2,866 shares of the business's stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $149.53, for a total value of $428,552.98. Following the completion of the sale, the director now directly owns 31,764 shares in the company, valued at approximately $4,749,670.92. The trade was a 8.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Leon E. Panetta sold 17,500 shares of the business's stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $151.24, for a total value of $2,646,700.00. Following the completion of the sale, the director now owns 58,090 shares of the company's stock, valued at approximately $8,785,531.60. This trade represents a 23.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 27,366 shares of company stock worth $4,015,723. 42.20% of the stock is currently owned by insiders.
Analyst Ratings Changes
A number of research analysts recently issued reports on the stock. Guggenheim reiterated a "buy" rating and issued a $220.00 price target on shares of Oracle in a research note on Thursday, April 3rd. BMO Capital Markets decreased their price target on shares of Oracle from $205.00 to $175.00 and set a "market perform" rating for the company in a research note on Tuesday, March 11th. Stephens assumed coverage on shares of Oracle in a research note on Wednesday, March 19th. They issued an "equal weight" rating and a $167.00 price target for the company. Evercore ISI decreased their price target on shares of Oracle from $200.00 to $185.00 and set an "outperform" rating for the company in a research note on Tuesday, March 11th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Oracle from $140.00 to $135.00 and set a "neutral" rating for the company in a research note on Tuesday, March 11th. Fourteen investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $174.42.
View Our Latest Analysis on ORCL
Oracle Stock Up 0.6%
Shares of NYSE ORCL traded up $0.92 during trading hours on Monday, hitting $166.45. The stock had a trading volume of 7,164,637 shares, compared to its average volume of 9,517,835. The company has a market capitalization of $465.55 billion, a P/E ratio of 40.70, a P/E/G ratio of 3.46 and a beta of 1.27. The firm's 50-day moving average price is $144.55 and its two-hundred day moving average price is $160.88. Oracle Co. has a 52 week low of $117.34 and a 52 week high of $198.31. The company has a debt-to-equity ratio of 5.65, a quick ratio of 0.81 and a current ratio of 0.81.
Oracle (NYSE:ORCL - Get Free Report) last announced its quarterly earnings results on Monday, March 10th. The enterprise software provider reported $1.47 EPS for the quarter, missing the consensus estimate of $1.49 by ($0.02). The firm had revenue of $14.13 billion during the quarter, compared to the consensus estimate of $14.40 billion. Oracle had a net margin of 21.16% and a return on equity of 133.25%. The company's quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.41 EPS. Analysts anticipate that Oracle Co. will post 5 EPS for the current fiscal year.
Oracle Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, April 23rd. Investors of record on Thursday, April 10th were issued a $0.50 dividend. This is a positive change from Oracle's previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a yield of 1.20%. The ex-dividend date of this dividend was Thursday, April 10th. Oracle's payout ratio is 46.95%.
About Oracle
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
See Also

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report